fenofibrate has been researched along with lysophosphatidylcholines in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arthur, G; Choy, PC; Dembinski, T; Hatch, GM; Kroeger, EA; Liang, B; Man, RY; McMaster, JC; Mymin, D; Shen, G | 1 |
| Akhmedzhanov, NM; Oganov, RG; Olfer'ev, AM; Ozerova, IN; Paramonova, IV; Pavlova, LI; Perova, NV | 1 |
| Sun, GJ; Xie, XM; Xing, Y; Yan, WH; Yang, TL; Yu, GL | 1 |
| Rosenson, RS | 1 |
1 trial(s) available for fenofibrate and lysophosphatidylcholines
| Article | Year |
|---|---|
Fenofibrate reduces lipoprotein associated phospholipase A2 mass and oxidative lipids in hypertriglyceridemic subjects with the metabolic syndrome.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adult; Dose-Response Relationship, Drug; Double-Blind Method; Fatty Acids, Nonesterified; Female; Fenofibrate; Follow-Up Studies; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Immunoenzyme Techniques; Intercellular Adhesion Molecule-1; Lysophosphatidylcholines; Magnetic Resonance Spectroscopy; Male; Metabolic Syndrome; Middle Aged; Treatment Outcome; Vascular Cell Adhesion Molecule-1 | 2008 |
3 other study(ies) available for fenofibrate and lysophosphatidylcholines
| Article | Year |
|---|---|
The effect of fenofibrate treatment on endothelium-dependent relaxation induced by oxidative modified low density lipoprotein from hyperlipidemic patients.
Topics: Acetylcholine; Animals; Aorta, Thoracic; Cholesterol; Cholesterol, LDL; Chromatography, Gas; Endothelium, Vascular; Fenofibrate; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipids; Lipoproteins, LDL; Lysophosphatidylcholines; Muscle, Smooth, Vascular; Oxidation-Reduction; Rats; Triglycerides; Vasodilation | 2000 |
Phospholipid composition of high-density lipoproteins reflects lipolysis of triglyceride-rich lipoproteins during hyperlipidemia.
Topics: Adult; Anticholesteremic Agents; Cardiolipins; Cholesterol; Cholesterol, HDL; Fenofibrate; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipolysis; Lipoproteins, HDL; Lysophosphatidylcholines; Male; Middle Aged; Phosphatidylcholines; Phosphatidylethanolamines; Phospholipids; Simvastatin; Sphingomyelins; Triglycerides | 2001 |
[Effects of fenofibrate on the proliferation and apoptosis and nitric oxide synthase expression of cultured human umbilical vein endothelial cells induced by lysophosphatidylcholine].
Topics: Apoptosis; Cell Proliferation; Cells, Cultured; Endothelium, Vascular; Fenofibrate; Humans; Hypolipidemic Agents; Lysophosphatidylcholines; Nitric Oxide Synthase Type III; RNA, Messenger; Umbilical Veins | 2006 |